Accessibility Menu
 
ProPhase Labs logo

ProPhase Labs

(NASDAQ) PRPH

Current PriceN/A
Market CapN/A
Since IPO (1992)-97%
5 YearN/A
1 YearN/A
1 Month-49%

ProPhase Labs Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$1.08M

Net Income (TTM)

$41.70M

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

PRPH News

PRPH: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About ProPhase Labs

Industry

Pharmaceuticals

Employees

96

CEO

Ted William Karkus, MBA

Headquarters

Garden City, NY 11530, US

PRPH Financials

Key Financial Metrics (TTM)

Gross Margin

2%

Operating Margin

-25%

Net Income Margin

-39%

Return on Equity

-4%

Return on Capital

-3%

Return on Assets

-63%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/A

Shares Outstanding

N/A

Volume

N/A

Short Interest

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

$150.00K

Operating Income

$38.63M

EBITDA

$32.34M

Operating Cash Flow

$17.54M

Capital Expenditure

$906.00K

Free Cash Flow

$18.44M

Cash & ST Invst.

$678.00K

Total Debt

$24.57M

ProPhase Labs Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2025YOY CHG

Revenue

$883.00K

-71.9%

Gross Profit

$123.00K

+25.5%

Gross Margin

-13.93%

N/A

Market Cap

N/A

N/A

Market Cap/Employee

N/A

N/A

Employees

96

N/A

Net Income

$6.84M

-3.8%

EBITDA

$4.39M

+19.1%

Quarterly Fundamentals

Name
Q3 2025YOY CHG

Net Cash

$7.28M

+74.5%

Accounts Receivable

$3.28M

-89.6%

Inventory

$266.00K

-93.3%

Long Term Debt

$965.00K

-95.6%

Short Term Debt

$6.72M

-10.9%

Return on Assets

-63.47%

N/A

Return on Invested Capital

-2.58%

N/A

Free Cash Flow

$21.52M

-411.7%

Operating Cash Flow

$21.52M

-434.1%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
AYTUAytu BioPharma, Inc.
$2.60-2.09%
TXMDTherapeuticsMD, Inc.
$2.10-5.41%
ALURAllurion Technologies Inc.
$0.78-5.95%
ERNAErnexa Therapeutics Inc.
$0.20-2.98%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDANvidia
$167.52-0.02%
TQQQProShares Trust - ProShares UltraPro Qqq
$38.78-0.06%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$8.28+0.05%
QQQInvesco QQQ Trust
$562.58-0.02%

Questions About PRPH

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.